v3.26.3
Revenue Recognition (Tables)
 9 Months Ended
Sep. 30, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregated Revenue by Major Geographical Region and Product Category
The following table provides information about disaggregated revenue by major geographical region:
Three Months Ended September 30,Nine Months Ended September 30,
(in Millions)2026202520262025
North America (1)
$(370.7)$244.4 $75.7 $751.7 
Latin America (1)
264.3 463.1 719.2 980.3 
Europe, Middle East & Africa (EMEA)121.0 154.5 642.0 687.7 
Asia (2)
91.3 (319.8)294.7 (35.6)
Total Revenue$105.9 $542.2 $1,731.6 $2,384.1 
____________________ 
(1)In response to challenging market conditions, we implemented comprehensive commercial actions in Brazil, Argentina, the United States and Canada to reflect pricing adjustments made on select products held by channel customers as well as modify our pricing and rebate model in North America. As a result, we recorded approximately $535 million and $104 million in revenue charges in North America and Latin America, respectively, during the three and nine months ended September 30, 2026.
(2)During the three and nine months ended September 30, 2025, we took several intentional commercial actions to prepare the India commercial business for sale. These actions to position the India business for sale resulted in revenue charges of $419 million for the India business in the third quarter of 2025 and included the recognition of actual inventory returns during the period, an increase to the reserve for future sales returns, and various pricing actions to assist with the acceleration of receivable collection. Refer to Note 1 for further details on the India held for sale business.
The following table provides information about disaggregated revenue by major product category:
Three Months Ended September 30,Nine Months Ended September 30,
(in Millions)2026202520262025
Insecticides$288.9 $204.4 $1,053.0 $1,132.4 
Herbicides(279.7)219.9 352.2 868.1 
Fungicides39.4 89.3 183.6 222.4 
Plant Health31.4 35.2 115.5 125.3 
Other25.9 (6.6)27.3 35.9 
Total Revenue (1)(2)
$105.9 $542.2 $1,731.6 $2,384.1 
____________________ 
(1)The three and nine months ended September 30, 2026 includes revenue charges of approximately $639 million in connection with commercial actions implemented during the period, which impacted the insecticides, herbicides, and fungicides product categories above.
(2)The three and nine months ended September 30, 2025 includes revenue charges of approximately $419 million driven by the intentional commercial actions to prepare the India commercial business for sale. Refer to Note 1 for further details on the India held for sale business.
Schedule of Opening and Closing Balances of Receivables and Contract Liabilities from Contracts With Customers
The following table presents the opening and closing balances of our receivables, net of allowances and contract liabilities from contracts with customers:
(in Millions)Balance as of September 30, 2026Balance as of December 31, 2025Increase (Decrease)
Receivables from contracts with customers, net of allowances (1)
$1,751.2 $2,137.1 $(385.9)
Contract liabilities: Advance payments from customers (2)
267.8 453.1 (185.3)
____________________ 
(1)Amount includes $1,723.1 million of trade receivables and $28.1 million of net long-term customer receivables as of September 30, 2026. See Note 5 for more information.
(2)Amount includes $67.8 million of short-term advance payments from customers and $200.0 million of long-term advance payments from customers as of September 30, 2026. The long-term advance payments from customers includes the deferred revenue recognized in connection with the licensing agreement discussed further below and recorded in Other long-term liabilities on the consolidated balance sheet. The amount of revenue recognized in the nine months ended September 30, 2026 that was included in the opening contract liability balance is $452.6 million.